Clinical Research, Pharma & Healthcare FinancingCyprumed, MSD Sign Deal for Oral Peptide TherapeuticsGlobeNewswireApril 15, 2025April 16, 2025 by GlobeNewswireApril 15, 2025April 16, 2025050 Cyprumed GmbH, a dedicated drug delivery company specializing in innovative oral peptide formulations, and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA), today...
